| Cyclin D–CDK4 kinase destabilizes PD-L1 via cullin 3–SPOP to control cancer immune surveillance J Zhang, X Bu, H Wang, Y Zhu, Y Geng, NT Nihira, Y Tan, Y Ci, F Wu, ... Nature 553 (7686), 91, 2018 | 913 | 2018 |
| Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy Y Gao, NT Nihira, X Bu, C Chu, J Zhang, A Kolodziejczyk, Y Fan, NT Chan, ... Nature Cell Biology, 1-12, 2020 | 292 | 2020 |
| Simvastatin induced HCT116 colorectal cancer cell apoptosis through p38MAPK-p53-survivin signaling cascade HL Chang, CY Chen, YF Hsu, WS Kuo, G Ou, PT Chiu, YH Huang, ... Biochimica et Biophysica Acta (BBA)-General Subjects 1830 (8), 4053-4064, 2013 | 76 | 2013 |
| Interleukin-6 induces vascular endothelial growth factor-C expression via Src-FAK-STAT3 signaling in lymphatic endothelial cells YH Huang, HY Yang, SW Huang, G Ou, YF Hsu, MJ Hsu PloS one 11 (7), e0158839, 2016 | 73 | 2016 |
| Trichostatin A and sirtinol suppressed survivin expression through AMPK and p38MAPK in HT29 colon cancer cells YF Hsu, JR Sheu, CH Lin, DS Yang, G Hsiao, G Ou, PT Chiu, YH Huang, ... Biochimica et Biophysica Acta (BBA)-General Subjects 1820 (2), 104-115, 2012 | 57 | 2012 |
| Src contributes to IL6-induced vascular endothelial growth factor-C expression in lymphatic endothelial cells YH Huang, HY Yang, YF Hsu, PT Chiu, G Ou, MJ Hsu Angiogenesis 17 (2), 407-418, 2014 | 48 | 2014 |
| Anti-cancer activity of an osthole derivative, NBM-T-BMX-OS01: Targeting vascular endothelial growth factor receptor signaling and angiogenesis HY Yang, YF Hsu, PT Chiu, SJ Ho, CH Wang, CC Chi, YH Huang, CF Lee, ... PloS one 8 (11), e81592, 2013 | 20 | 2013 |
| Src-FAK Signaling Mediates Interleukin 6-Induced HCT116 Colorectal Cancer Epithelial–Mesenchymal Transition YH Huang, HK Chen, YF Hsu, HC Chen, CH Chuang, SW Huang, MJ Hsu International Journal of Molecular Sciences 24 (7), 6650, 2023 | 12 | 2023 |
| The effects of a novel aliphatic-chain hydroxamate derivative WMJ-S-001 in HCT116 colorectal cancer cell death YH Huang, SW Huang, YF Hsu, G Ou, WJ Huang, MJ Hsu Scientific reports 5, 15900, 2015 | 8 | 2015 |
| Suppressing VEGF-A/VEGFR-2 Signaling Contributes to the Anti-Angiogenic Effects of PPE8, a Novel Naphthoquinone-Based Compound MJ Hsu, HK Chen, JC Lien, YH Huang, SW Huang Cells 11 (13), 2114, 2022 | 6 | 2022 |
| Anti-Angiogenetic and Anti-Lymphangiogenic Effects of a Novel 2-Aminobenzimidazole Derivative, MFB MJ Hsu, HK Chen, CY Chen, JC Lien, JY Gao, YH Huang, JBK Hsu, ... Frontiers in Oncology, 2910, 2022 | 6 | 2022 |
| COMPOSITIONS AND METHODS FOR TREATING USHER SYNDROME GG Geleoc, SA Mauriac, TW Yu, YH Huang, K Koehler US Patent App. U.S. Provisional Application No. 63/549,313, 2024 | | 2024 |
| Antisense oligonucleotide-based progranulin augmentation therapy in neurodegenerative diseases PJ Park, JK Kim, T Yu, YH Huang US Patent App. 17/440,438, 2022 | | 2022 |
| ANTISENSE OLIGONUCLEOTIDE-BASED PROGRANULIN AUGMENTATION THERAPY IN NEURODEGENERATIVE DISEASES PJ Park, J Kim, YH Huang, TW Yu WO Patent WO/2020/191,212, 2020 | | 2020 |
